ONO PHARMA USA Announces 2024 Golden Ticket Competition Now Accepting Applications from Innovative Startups [Yahoo! Finance]
Ono Pharmaceutical acquires cancer-focused biopharma Deciphera for $2.4bn [Yahoo! Finance]
XCOPRI® (cenobamate tablets) CV Receives FDA Approval for Alternate Methods of Administration That Include Crushed Tablet in Liquid Suspension Taken Orally or Through a Nasogastric Tube [Yahoo! Finance]
SK Life Science Announces Data Presentations for XCOPRI® (cenobamate tablets) CV at the 2024 American Academy of Neurology Annual Meeting [Yahoo! Finance]
ONO PHARMA Announces Enrollment is Complete for the First Arm of the PROSPECT Study of Tirabrutinib in U.S. Patients with Relapsed or Refractory PCNSL [Yahoo! Finance]